1Cunning FG, Mac Donald PC, Grant NF,et al. Drugs and medications du ring pregnancy. In: Williams Obstetrics [ M ]. 19th ed. Norwalk: Appleton and Lange, 1996. 959.
3Briggs CG, Bodendorfer TN, Freeman RK, et al. Drugs in Pregnancy and Lactation [ M ]. Willian & Wimkins, Baltimore / London, 1983.
4Boothby LA, Doering PL. FDA lalelling system in pregnancy[ J]. Ann pharmaeother, 2001,35 : 1485 - 1489.
5Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients[J]. Pak J Pharm Sci,2008,21 (2) : 185 - 194.
7Antiepileptic dnigs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies [ J ]. Epilepsia, 2006,3:117 - 123.
8Sato A, Fujiinori K, Sonoda M. Precautions in use of drugs for pregnancy and lactating women [ J 1. Nippon Rinsho, 2007, 28 (8) : 35 -41.
9Booth LA, Doering PL. FDA lalelling system in pregnancy [ J ].Ann pharmaeother,2001,35 : 1485 - 1489.
10shiono PH, Mils JL. Oral clefts and driazepam use during pergnancy[J]. N Engl J Med,1984,311:919 -920.
